Peng Z, Wei J, Wang F, Ying J, et al. Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as
First-line Therapy for Advanced Gastric or Gastroesophageal Junction
Adenocarcinoma. Clin Cancer Res 2021;27:3069-3078.
PMID: 33766817